Acurx Pharmaceuticals, Inc. (ACXP)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 54
-0.03
-1.9108%
$
2.49M Market Cap
- P/E Ratio
- Div Yield
72,145 Volume
- Eps
$ 1.57
Previous Close 
Analysts:
Want to track ACXP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acurx Pharmaceuticals, Inc. (ACXP) Statistics
Valuation metrics
Market Cap 2.49M
Enterprise value -6.77M
Trailing P/E (ttm) -0.31
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.34
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.89
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 43.44K
Average volume (90 days) 639.91K
Price summary
52-Week low 1.33
52-Week high 21
Beta -
50-Day moving average 1.98
200-Day moving average 2.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 5 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.79%
Return on equity -1.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.17
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.78%
Book value per share (mrq) 4.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
